SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000899923-22-000059
Filing Date
2022-04-14
Accepted
2022-04-14 16:11:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-2022proxyadditiona.htm DEFA14A 8474
2 myriadgeneticsinc_vsmvxnaxb.jpg GRAPHIC 91477
3 myriadgeneticsinc_vsmvxnaxc.jpg GRAPHIC 113089
  Complete submission text file 0000899923-22-000059.txt   291440
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 22827368
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences